Dr. Daniel Anjin Hidaka , MD
Internal Medicine • Glenview, IL
2501 Compass Rd Ste 140
Glenview, IL 600268000
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Daniel Hidaka is listed in NPPES under Internal Medicine.
-
NPI assigned on July 4, 2008; this date does not establish years in practice.
-
Published CMS data list 48 Original Medicare Part B services in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Published rows only; this is not a quality measure.
-
Published Part B service records, 2019:
- 99214 — Established patient outpatient office visit: 48 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2018 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2019). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 372 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 52 prescription fills, including refills.
- Atorvastatin Calcium — 46 prescription fills, including refills.
- Gabapentin — 20 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 80% of clinicians listed under Internal Medicine in Glenview, IL (2024, 34 clinicians with data). Median for this group: 3,585. Middle half: 1,567 to 6,494.
Close to the middle for Part D prescriptions among clinicians listed under Internal Medicine in Illinois (2024, 3,755 clinicians with data). Median for this group: 1,030. Middle half: 99 to 4,658.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,287 in 2017 to 48 in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017–2019.
Practice Location & Contact Primary Location
2501 Compass Rd Ste 140
Glenview, IL 600268000
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $5,291 in 2019
The total amount Medicare approved for these services in 2019. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
Paid by Medicare
About $3,919 in 2019
The part of the Medicare-allowed amount that Medicare itself paid in 2019, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
30-day fills
960 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$42,747 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $60.00 across 4 records.
By nature of payment
- Food and Beverage: $60.00 across 4 records.
Reporting-company totals
- Phathom Pharmaceuticals, Inc.: $26.43 across 2 records.
- Eli Lilly and Company: $19.05 across 1 record.
- AstraZeneca Pharmaceuticals LP: $14.52 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2008
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Can order Medicare-covered services
CMS lists Dr. Hidaka as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Glenview and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 80% of clinicians listed under Internal Medicine in Glenview, IL (2024, 34 clinicians with data). Median for this group: 3,585. Middle half: 1,567 to 6,494.
Close to the middle for clinicians listed under Internal Medicine in Illinois (2024, 3,755 clinicians with data). Median for this group: 1,030. Middle half: 99 to 4,658.
Part D drug cost
A lower Part D drug cost than 80% of clinicians listed under Internal Medicine in Glenview, IL (2024, 34 clinicians with data). Median for this group: $195,520. Middle half: $82,567 to $360,396.
Close to the middle for clinicians listed under Internal Medicine in Illinois (2024, 3,755 clinicians with data). Median for this group: $78,716. Middle half: $2,604 to $371,507.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Hidaka are from 2019.
57 active clinicians are listed under Internal Medicine with a practice address in Glenview, IL (7,245 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Glenview
38.6% of these 57 clinicians have the CMS telehealth indicator.
54.4% of these 57 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 96% from 1,287 in 2017 to 48 in 2019.
- 2017: 1,287
- 2018: 1,009
- 2019: 48
-
Medicare-allowed amount
Medicare-allowed amount decreased 95% from $105,828 in 2017 to $5,291 in 2019.
- 2017: $105,828
- 2018: $82,062
- 2019: $5,291
-
Paid by Medicare
Paid by Medicare decreased 95% from $81,769 in 2017 to $3,919 in 2019.
- 2017: $81,769
- 2018: $64,705
- 2019: $3,919
-
Medicare Part D prescriptions
Medicare Part D prescriptions went from 14 in 2020 to 372 in 2024.
- 2020: 14
- 2021: 163
- 2022: 277
- 2023: 261
- 2024: 372
-
30-day fills
30-day fills went from 14 in 2020 to 960 in 2024.
- 2020: 14
- 2021: 297
- 2022: 634
- 2023: 661
- 2024: 960
-
Part D drug cost
Part D drug cost went from $425 in 2020 to $42,747 in 2024.
- 2020: $425
- 2021: $48,148
- 2022: $18,971
- 2023: $6,298
- 2024: $42,747
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $15.88 in 2020 to $60.00 in 2025.
- 2020: $15.88
- 2021: $21.93
- 2022: $79.52
- 2023: $16.52
- 2025: $60.00
Sources: CMS Medicare Physician & Other Practitioners (2019), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $60.00.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $19.05 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $14.52 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
VOQUEZNA | General | $14.44 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
VOQUEZNA | General | $11.99 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2018 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2019; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
48 | 36 | $114.06 | $110.23 |
Source: CMS Part B by Provider and Service, 2019; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 52 | 4,590 | $540.77 | 18 |
| Atorvastatin Calcium | Atorvastatin Calcium | 46 | 4,080 | $652.89 | 14 |
| Gabapentin | Gabapentin | 20 | 898 | $170.78 | — |
| Levothyroxine Sodium | Levothyroxine Sodium | 20 | 1,800 | $402.68 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 19 | 1,710 | $358.62 | — |
| Amlodipine Besylate | Amlodipine Besylate | 18 | 1,560 | $146.95 | — |
| Metoprolol Succinate | Metoprolol Succinate | 18 | 1,544 | $306.09 | — |
| Azithromycin | Azithromycin | 17 | 79 | $78.01 | 14 |
| Tamsulosin Hcl | Tamsulosin Hcl | 15 | 1,350 | $403.61 | — |
| Memantine Hcl | Memantine Hcl | 15 | 660 | $104.16 | — |
| Ezetimibe | Ezetimibe | 14 | 1,170 | $200.69 | — |
| Lisinopril | Lisinopril | 13 | 1,170 | $22.93 | — |
| Metformin Hcl | Metformin Hcl | 13 | 1,170 | $214.52 | — |
| Eliquis | Apixaban | 13 | 1,110 | $20,178.53 | — |
| Tramadol Hcl | Tramadol Hcl | 12 | 262 | $61.41 | — |
| Methylprednisolone | Methylprednisolone | 12 | 72 | $100.18 | — |
| Hydrochlorothiazide | Hydrochlorothiazide | 11 | 990 | $77.92 | — |
| Synthroid | Levothyroxine Sodium | 11 | 900 | $766.52 | — |
| Bupropion Xl | Bupropion Hcl | 11 | 810 | $432.79 | — |
| Irbesartan | Irbesartan | 11 | 990 | $399.44 | — |
| Myrbetriq | Mirabegron | 11 | 990 | $17,127.49 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-07-15NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Practice Nurse, Family Nurse Practitioner (Board Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 2501 COMPASS RD STE 140, GLENVIEW, IL 600268000 (Tel: 8559477371)
Registered at 2501 COMPASS RD STE 140, GLENVIEW, IL 600268000 (Tel: 8559477371)
Registered at 737 N MICHIGAN AVE STE 2020, CHICAGO, IL 606116749 (Tel: 8559477371)
Registered at 737 N MICHIGAN AVE STE 2020, CHICAGO, IL 606116749 (Tel: 8559477371)
NPI status registered as active in NPPES database
Registered at 259 E ERIE ST, SUITE 2350, CHICAGO, IL 606112987 (Tel: 3129266000)
Registered at 259 E ERIE ST, SUITE 2350, CHICAGO, IL 606112987 (Tel: 3129266000)
Recorded as DANIEL HIDAKA, M.D.
Internal Medicine (license number reported to NPPES: IL 036122562)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Glenview
- Dr. Johan Lane, MD
- Dr. Rimma Polotskaya, MD
- Dr. Deepali Ahluwalia, MD
- Dr. Maria Michelotti, MD
- Dr. Jasmin Bir, MD
- Dr. Greg Denenberg, MD
Mailing Address
2501 Compass Rd Ste 140
Glenview, IL 600268000
Phone: 8559477371